drugset / Trial / NCT05148754
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
RandomizedSequentialOpen-labelTreatment
Summary
An open-label clinical study of the pharmacokinetics and safety of Elsulfavirine, 200 mg tablets, with single and multiple oral administration in healthy volunteers.
Timeline
- Start
- 2021-01-23
- Primary completion
- 2021-08-15
- Completion
- 2021-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elsulfavirine | Small molecule | 200 mg | Oral |
| Subject | Elsulfavirine | Small molecule | 400 mg | Oral |
| Subject | Elsulfavirine | Small molecule | 800 mg | Oral |
| Subject | Elsulfavirine | Small molecule | 1200 mg | Oral |